Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate

World News: . []

Valneva has previously reported LINK  booster data and final Phase 1 follow-up data for VLA15 confirming that the LINK  candidate has a favorable LINK  profile and was immunogenic in all doses and formulations tested VLA15 LINK  an excelle nt anam...

More news and information about VALNEVA

Published By:

Globe Newswire: 16:50 GMT Wednesday 12th June 2019

Published: .

Search for other references to "valneva" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us